文献速递药疹与重症皮肤不良反应

HLA-B*13:01在氨苯砜诱导的严重皮肤不良反应发病机制中的功能

The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions.
PubMed 文献 · J Invest Dermatol · 2018-02-17

研究纳入台湾和马来西亚的氨苯砜所致DRESS及斑丘疹患者,发现HLA-B*13:01等位基因在DRESS患者中占85.7%(6/7),比值比=49.64(95%置信区间=5.89-418.13;校正P=2.92×10⁻⁴),而台湾一般人群对照仅10.8%(73/677)。DRESS患者血浆颗粒溶素升高(36.14±9.02 ng/ml,P<0.05),体外淋巴细胞活化试验阳性率71.4%(5/7),且氨苯砜特异性细胞毒性T细胞与表达HLA-B*13:01的抗原提呈细胞共培养时显著活化(较无HLA-B*13:01表达细胞增加3.9倍,P<0.01)。

要点

  • HLA-B*13:01与氨苯砜所致DRESS强相关,比值比=49.64(95%置信区间=5.89-418.13)。
  • DRESS患者血浆颗粒溶素升高(36.14±9.02 ng/ml,P<0.05)。
  • 氨苯砜特异性细胞毒性T细胞在HLA-B*13:01表达抗原提呈细胞存在时活化增加3.9倍(P<0.01)。

核心结论

  • HLA-B*13:01与氨苯砜所致DRESS强相关,并描述了氨苯砜诱导的HLA限制性免疫机制的功能作用。

研究设计与样本

  • 研究纳入来自台湾和马来西亚的氨苯砜所致DRESS及伴有慢性炎症性皮肤病的斑丘疹患者,检测遗传易感性、HLA-B*13:01功能及细胞毒性T细胞。

主要发现

  • HLA-B*13:01等位基因在氨苯砜DRESS患者中占85.7%(6/7),在台湾一般人群对照中占10.8%(73/677),比值比=49.64(95%置信区间=5.89-418.13;校正P=2.92×10⁻⁴)。
  • DRESS患者血浆颗粒溶素水平为36.14±9.02 ng/ml(P<0.05),体外淋巴细胞活化试验阳性率为71.4%(5/7)。
  • 氨苯砜特异性细胞毒性T细胞与表达HLA-B*13:01的抗原提呈细胞在氨苯砜存在下共培养时显著活化,较无HLA-B*13:01表达的细胞增加3.9倍(P<0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dapsone-induced hypersensitivity reactions may cause severe cutaneous adverse reactions, such as drug reaction with eosinophilia and systemic symptoms (DRESS). It has been reported that HLA-B*13:01 is strongly associated with dapsone-induced hypersensitivity reactions among leprosy patients. However, the phenotype specificity and detailed immune mechanism of HLA-B*13:01 remain unclear. We investigated the genetic predisposition, HLA-B*13:01 function, and cytotoxic T cells involved in the pathogenesis of dapsone-induced severe cutaneous adverse reactions. We enrolled patients from Taiwan and Malaysia with DRESS and maculopapular eruption with chronic inflammatory dermatoses. Our results showed that the HLA-B*13:01 allele was present in 85.7% (6/7) of patients with dapsone DRESS (odds ratio = 49.64, 95% confidence interval = 5.89-418.13; corrected P = 2.92 × 10-4) but in only 10.8% (73/677) of general population control individuals in Taiwan. The level of granulysin, the severe cutaneous adverse reaction-specific cytotoxic protein released from cytotoxic T cells, was increased in both the plasma of DRESS patients (36.14 ± 9.02 ng/ml, P < 0.05) and in vitro lymphocyte activation test (71.4%, 5/7 patients) compared with healthy control individuals. Furthermore, dapsone-specific cytotoxic T cells were significantly activated when co-cultured with HLA-B*13:01-expressing antigen presenting cells in the presence of dapsone (3.9-fold increase, compared with cells with no HLA-B*13:01 expression; P < 0.01). This study indicates that HLA-B*13:01 is strongly associated with dapsone DRESS and describes a functional role for the HLA-restricted immune mechanism induced by dapsone.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Chen WT, Wang CW, Lu CW, et al. The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions. J Invest Dermatol. 2018. PMID: 29458119. doi:10.1016/j.jid.2018.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。